Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIi pseudogene 1 (GTF2IP1) is a pseudogene located near the commonly deleted region in Williams-Beuren syndrome on chromosome 7q11.23. Unlike GTF2I, which is a functional protein-coding gene encoding the transcription factor TFII-I, GTF2IP1 is a partially truncated, expressed pseudogene that does not produce a functional protein product and is not implicated as a therapeutic target. Its main relevance is as a genomic marker near chromosomal rearrangement breakpoints, potentially predisposing to unequal recombination in Williams-Beuren syndrome, but it does not have known molecular, biological, or disease roles nor interactions with drugs[3]. GTF2IP1 is a pseudogene, not a functional gene or actionable therapeutic target. Pseudogenes do not produce active proteins[3]. The functional paralog/related gene in this locus is GTF2I (General transcription factor IIi), a multifunctional transcription factor involved in transcriptional regulation, with disease roles in Williams-Beuren syndrome and potentially other conditions[2][4]. References in the literature to regulatory or disease functions concern GTF2I or GTF2IRD1, not GTF2IP1 itself[1][2][5]. If you are looking for the functional molecule in this region, the canonical entry should be: GTF2I (General transcription factor IIi) — not GTF2IP1. If you intended to inquire about the pseudogene as a putative target, it is not considered a valid biological target for therapeutic intervention or research in a classic sense[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIi pseudogene 1 (GTF2IP1).